News
Wedbush Initiates Coverage On Ovid Therapeutics with Outperform Rating, Announces Price Target of $8
5 Apr 24
News, Price Target, Initiation, Analyst Ratings
Recap: Ovid Therapeutics Q4 Earnings
8 Mar 24
Earnings
Ovid Therapeutics Q4 2023 GAAP EPS $(0.220) Misses $(0.100) Estimate, Sales $141.562K Beat $56.500K Estimate
8 Mar 24
Earnings, Earnings Beats, Earnings Misses, News